Circulating Drivers of Pathophysiology in Post-COVID-19 Sequelae.

Publication date: Aug 05, 2026

According to the WHO, post-COVID-19 sequelae impose an increased burden of illness and comorbidities among survivors. The present study evaluated systemic clinical complications associated with the dysregulation of circulatory cytokines in post-COVID-19 patients and compared them with those of healthy controls. This cross-sectional study included 147 participants divided into symptomatic post-COVID-19, asymptomatic post-COVID-19, and healthy control groups. After obtaining informed consent, peripheral blood samples were collected and analyzed using ELISA and RT-qPCR. Circulating levels of pro-inflammatory (IL-6, IL1β, TNFα) and anti-inflammatory cytokine IL-10 were measured in relation to clinical sequelae. Common symptoms were fatigue (48%), headache (48%), anxiety (64%), general weakness (70%), muscle pain (70%), joint pain (54%), chest pain (32%), dyspnea (36%), and post-activity tachypnea (40%) among post COVID-19 individulas. A higher prevalence of post-COVID-19 sequelae was observed in females aged >40 years and in those with a post-COVID-19 duration of

Open Access PDF

Concepts Keywords
cytokines
gene expression
Immune biomarkers
inflammation
post-COVID-19
sequelae

Semantics

Type Source Name
disease MESH COVID-19
disease MESH included
drug DRUGBANK Interleukin-10
disease MESH fatigue
disease MESH headache
disease MESH anxiety
disease MESH muscle pain
disease MESH joint pain
disease MESH chest pain
disease MESH dyspnea
disease MESH tachypnea
disease MESH Long Covid
disease MESH infection
disease MESH musculoskeletal pain
disease MESH chronic fatigue syndrome
disease MESH influenza
disease MESH inflammatory bowel disease
pathway KEGG Inflammatory bowel disease
disease MESH fibromyalgia
disease MESH carcinoma
disease MESH schizophrenia
disease MESH bipolar disorder
disease MESH RAD
drug DRUGBANK Albendazole
disease MESH abdominal pain
disease MESH diarrhea
disease MESH inflammation

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *